256 related articles for article (PubMed ID: 29632713)
1. CD47 is a direct target of SNAI1 and ZEB1 and its blockade activates the phagocytosis of breast cancer cells undergoing EMT.
Noman MZ; Van Moer K; Marani V; Gemmill RM; Tranchevent LC; Azuaje F; Muller A; Chouaib S; Thiery JP; Berchem G; Janji B
Oncoimmunology; 2018; 7(4):e1345415. PubMed ID: 29632713
[TBL] [Abstract][Full Text] [Related]
2. The immune checkpoint ligand PD-L1 is upregulated in EMT-activated human breast cancer cells by a mechanism involving ZEB-1 and miR-200.
Noman MZ; Janji B; Abdou A; Hasmim M; Terry S; Tan TZ; Mami-Chouaib F; Thiery JP; Chouaib S
Oncoimmunology; 2017; 6(1):e1263412. PubMed ID: 28197390
[TBL] [Abstract][Full Text] [Related]
3. The nuclear protein expression levels of SNAI1 and ZEB1 are involved in the progression and lymph node metastasis of cervical cancer via the epithelial-mesenchymal transition pathway.
Chen Z; Li S; Huang K; Zhang Q; Wang J; Li X; Hu T; Wang S; Yang R; Jia Y; Sun H; Tang F; Zhou H; Shen J; Ma D; Wang S
Hum Pathol; 2013 Oct; 44(10):2097-105. PubMed ID: 23791009
[TBL] [Abstract][Full Text] [Related]
4. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
[TBL] [Abstract][Full Text] [Related]
5. Cancer immunotherapy targeting the CD47/SIRPα axis.
Weiskopf K
Eur J Cancer; 2017 May; 76():100-109. PubMed ID: 28286286
[TBL] [Abstract][Full Text] [Related]
6. Effects of long noncoding RNA-ROR on tamoxifen resistance of breast cancer cells by regulating microRNA-205.
Zhang HY; Liang F; Zhang JW; Wang F; Wang L; Kang XG
Cancer Chemother Pharmacol; 2017 Feb; 79(2):327-337. PubMed ID: 28063065
[TBL] [Abstract][Full Text] [Related]
7. A function-blocking CD47 antibody modulates extracellular vesicle-mediated intercellular signaling between breast carcinoma cells and endothelial cells.
Kaur S; Elkahloun AG; Singh SP; Arakelyan A; Roberts DD
J Cell Commun Signal; 2018 Mar; 12(1):157-170. PubMed ID: 29188480
[TBL] [Abstract][Full Text] [Related]
8. The pan-inhibitor of Aurora kinases danusertib induces apoptosis and autophagy and suppresses epithelial-to-mesenchymal transition in human breast cancer cells.
Li JP; Yang YX; Liu QL; Zhou ZW; Pan ST; He ZX; Zhang X; Yang T; Pan SY; Duan W; He SM; Chen XW; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():1027-62. PubMed ID: 25733818
[TBL] [Abstract][Full Text] [Related]
9. CD47 Blockade and Cowpea Mosaic Virus Nanoparticle In Situ Vaccination Triggers Phagocytosis and Tumor Killing.
Wang C; Steinmetz NF
Adv Healthc Mater; 2019 Apr; 8(8):e1801288. PubMed ID: 30838815
[TBL] [Abstract][Full Text] [Related]
10. FBXL10 promotes EMT and metastasis of breast cancer cells via regulating the acetylation and transcriptional activity of SNAI1.
Yang Y; Zhao B; Lv L; Yang Y; Li S; Wu H
Cell Death Discov; 2021 Oct; 7(1):328. PubMed ID: 34718323
[TBL] [Abstract][Full Text] [Related]
11. 53BP1 suppresses epithelial-mesenchymal transition by downregulating ZEB1 through microRNA-200b/429 in breast cancer.
Kong X; Ding X; Li X; Gao S; Yang Q
Cancer Sci; 2015 Aug; 106(8):982-9. PubMed ID: 26011542
[TBL] [Abstract][Full Text] [Related]
12. Scleraxis regulates Twist1 and Snai1 expression in the epithelial-to-mesenchymal transition.
Al-Hattab DS; Safi HA; Nagalingam RS; Bagchi RA; Stecy MT; Czubryt MP
Am J Physiol Heart Circ Physiol; 2018 Sep; 315(3):H658-H668. PubMed ID: 29906225
[TBL] [Abstract][Full Text] [Related]
13. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
14. Resistin induces breast cancer cells epithelial to mesenchymal transition (EMT) and stemness through both adenylyl cyclase-associated protein 1 (CAP1)-dependent and CAP1-independent mechanisms.
Avtanski D; Garcia A; Caraballo B; Thangeswaran P; Marin S; Bianco J; Lavi A; Poretsky L
Cytokine; 2019 Aug; 120():155-164. PubMed ID: 31085453
[TBL] [Abstract][Full Text] [Related]
15. Tumor suppressor role of cytoplasmic polyadenylation element binding protein 2 (CPEB2) in human mammary epithelial cells.
Tordjman J; Majumder M; Amiri M; Hasan A; Hess D; Lala PK
BMC Cancer; 2019 Jun; 19(1):561. PubMed ID: 31185986
[TBL] [Abstract][Full Text] [Related]
16. PD-L1 expression is associated with epithelial-to-mesenchymal transition in adenocarcinoma of the lung.
Kim S; Koh J; Kim MY; Kwon D; Go H; Kim YA; Jeon YK; Chung DH
Hum Pathol; 2016 Dec; 58():7-14. PubMed ID: 27473266
[TBL] [Abstract][Full Text] [Related]
17. Programmed death-ligand 1 expression at tumor invasive front is associated with epithelial-mesenchymal transition and poor prognosis in esophageal squamous cell carcinoma.
Tsutsumi S; Saeki H; Nakashima Y; Ito S; Oki E; Morita M; Oda Y; Okano S; Maehara Y
Cancer Sci; 2017 Jun; 108(6):1119-1127. PubMed ID: 28294486
[TBL] [Abstract][Full Text] [Related]
18. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H
J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616
[TBL] [Abstract][Full Text] [Related]
19. HIF-1α Promotes Epithelial-Mesenchymal Transition and Metastasis through Direct Regulation of ZEB1 in Colorectal Cancer.
Zhang W; Shi X; Peng Y; Wu M; Zhang P; Xie R; Wu Y; Yan Q; Liu S; Wang J
PLoS One; 2015; 10(6):e0129603. PubMed ID: 26057751
[TBL] [Abstract][Full Text] [Related]
20. miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2.
Ma P; Ni K; Ke J; Zhang W; Feng Y; Mao Q
Exp Biol Med (Maywood); 2018 Mar; 243(5):473-480. PubMed ID: 29368542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
